id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
354,,,,,,,,,,,,,,,2024-06-26T16:55:17+06:00,BSH - H12307354341,Right,,,,"4 cycles of ChT with Paclitaxel upto 10.04.18> Completed ChT with Pacli 300 mg @ 3 week
interval till 12.07.18 (Indian protocol)> Received ZA @ 4 weeks interval+ Zoladex 3.6 mg SC till 30.07.22>
06 cycles Doce+ Carbo till 30.01.23> M11 with trastuzumab till 25.06.23, M12 due on 16.07.23 > Now on
oral chemo with Tab Lapatinib+Tab Capecitabine.",2024-03-07,,2024-04-07,,2023-08-16,2023-08-16,,Breast,339,,BSBSC-240000339,ROKEYA SULTANA,1817547353,1980-02-06,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Right,,,Progressed,Alive,CR,,,,CR,,,,,,,,,,,,,,,,,
